Clinical use of nefazodone in major depression: a 6-year perspective

J Clin Psychiatry. 2002:63 Suppl 1:18-31.

Authors

Alan F Schatzberg¹, Maureen R Prather, Martin B Keller, A John Rush, Lyle K Laird, Clinton W Wright

Affiliation

¹ Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Calif 94305-5717, USA. afschatz@Stanford.edu

PMID: 11890561

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Review

MeSH terms

Age Factors
Antidepressive Agents, Second-Generation / pharmacology
Antidepressive Agents, Second-Generation / therapeutic use*
Chronic Disease
Depressive Disorder / drug therapy*
Hospitalization
Humans
Meta-Analysis as Topic
Piperazines
Randomized Controlled Trials as Topic
Secondary Prevention
Selective Serotonin Reuptake Inhibitors / pharmacology
Selective Serotonin Reuptake Inhibitors / therapeutic use
Sleep / drug effects
Triazoles / pharmacology
Triazoles / therapeutic use*

Substances

Antidepressive Agents, Second-Generation
Piperazines
Serotonin Uptake Inhibitors
Triazoles
nefazodone